Unichem Laboratories Past Earnings Performance
Past criteria checks 2/6
Unichem Laboratories's earnings have been declining at an average annual rate of -31.4%, while the Pharmaceuticals industry saw earnings growing at 14.2% annually. Revenues have been growing at an average rate of 5.2% per year. Unichem Laboratories's return on equity is 0.6%, and it has net margins of 0.9%.
Key information
-31.4%
Earnings growth rate
-31.7%
EPS growth rate
Pharmaceuticals Industry Growth | 17.5% |
Revenue growth rate | 5.2% |
Return on equity | 0.6% |
Net Margin | 0.9% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Optimistic Investors Push Unichem Laboratories Limited (NSE:UNICHEMLAB) Shares Up 26% But Growth Is Lacking
Feb 06Is Unichem Laboratories (NSE:UNICHEMLAB) Using Debt Sensibly?
Feb 01Does Unichem Laboratories (NSE:UNICHEMLAB) Have A Healthy Balance Sheet?
Sep 06Unichem Laboratories (NSE:UNICHEMLAB) Is Due To Pay A Dividend Of ₹4.00
Jul 30There's Reason For Concern Over Unichem Laboratories Limited's (NSE:UNICHEMLAB) Massive 28% Price Jump
Jul 23Unichem Laboratories (NSE:UNICHEMLAB) Will Pay A Dividend Of ₹4.00
Jul 15Unichem Laboratories (NSE:UNICHEMLAB) Will Pay A Dividend Of ₹4.00
Jul 01Unichem Laboratories (NSE:UNICHEMLAB) Is Making Moderate Use Of Debt
Nov 27Investors Shouldn't Be Too Comfortable With Unichem Laboratories' (NSE:UNICHEMLAB) Robust Earnings
Jun 05Should Unichem Laboratories Limited (NSE:UNICHEMLAB) Be Part Of Your Income Portfolio?
Mar 02Unichem Laboratories Limited's (NSE:UNICHEMLAB) Stock's Been Going Strong: Could Weak Financials Mean The Market Will Correct Its Share Price?
Feb 09Should You Take Comfort From Insider Transactions At Unichem Laboratories Limited (NSE:UNICHEMLAB)?
Jan 19Do Institutions Own Unichem Laboratories Limited (NSE:UNICHEMLAB) Shares?
Dec 29Is Unichem Laboratories (NSE:UNICHEMLAB) Weighed On By Its Debt Load?
Dec 10Key Things To Understand About Unichem Laboratories' (NSE:UNICHEMLAB) CEO Pay Cheque
Nov 23Did Unichem Laboratories' (NSE:UNICHEMLAB) Share Price Deserve to Gain 41%?
Nov 02Should You Buy Unichem Laboratories Limited (NSE:UNICHEMLAB) For Its 1.5% Dividend?
Oct 13How Much Are Unichem Laboratories Limited (NSE:UNICHEMLAB) Insiders Spending On Buying Shares?
Sep 16Is Unichem Laboratories (NSE:UNICHEMLAB) Using Too Much Debt?
Aug 26Is Unichem Laboratories Limited's (NSE:UNICHEMLAB) Shareholder Ownership Skewed Towards Insiders?
Aug 05Would Shareholders Who Purchased Unichem Laboratories'(NSE:UNICHEMLAB) Stock Three Years Be Happy With The Share price Today?
Jul 14Revenue & Expenses BreakdownBeta
How Unichem Laboratories makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 16,753 | 146 | 3,950 | 0 |
30 Sep 23 | 15,434 | -1,333 | 3,874 | 0 |
30 Jun 23 | 14,566 | -1,795 | 3,675 | 0 |
31 Mar 23 | 13,430 | -2,022 | 3,690 | 0 |
31 Dec 22 | 13,109 | -865 | 3,696 | 0 |
30 Sep 22 | 13,197 | -367 | 3,614 | 0 |
30 Jun 22 | 12,815 | 212 | 3,530 | 0 |
31 Mar 22 | 12,698 | 331 | 3,468 | 0 |
31 Dec 21 | 11,740 | -388 | 3,253 | 0 |
30 Sep 21 | 11,890 | -12 | 3,211 | 0 |
30 Jun 21 | 12,158 | 204 | 3,152 | 0 |
31 Mar 21 | 12,351 | 343 | 3,113 | 0 |
31 Dec 20 | 13,581 | 175 | 3,112 | 0 |
30 Sep 20 | 13,067 | -206 | 2,989 | 0 |
30 Jun 20 | 12,547 | -516 | 2,916 | 0 |
31 Mar 20 | 11,037 | -602 | 2,786 | 0 |
31 Dec 19 | 12,653 | -113 | 2,745 | 0 |
30 Sep 19 | 12,711 | 51 | 2,697 | 0 |
30 Jun 19 | 12,366 | -113 | 2,567 | 0 |
31 Mar 19 | 11,800 | -256 | 2,475 | 0 |
31 Dec 18 | 10,425 | -591 | 2,319 | 0 |
31 Mar 18 | 8,146 | -1,331 | 2,090 | 0 |
31 Dec 17 | 15,855 | 405 | 4,258 | 585 |
31 Mar 17 | 6,977 | -707 | 1,806 | 0 |
31 Mar 16 | 13,327 | 1,081 | 3,311 | 416 |
31 Mar 15 | 12,018 | 754 | 3,004 | 446 |
31 Mar 14 | 11,334 | 1,282 | 4,380 | 505 |
Quality Earnings: UNICHEMLAB has a large one-off gain of ₹448.0M impacting its last 12 months of financial results to 31st December, 2023.
Growing Profit Margin: UNICHEMLAB became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: UNICHEMLAB has become profitable over the past 5 years, growing earnings by -31.4% per year.
Accelerating Growth: UNICHEMLAB has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: UNICHEMLAB has become profitable in the last year, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (23.1%).
Return on Equity
High ROE: UNICHEMLAB's Return on Equity (0.6%) is considered low.